It all assumes that Regeneron executes their rollout effectively. Remember how Immunex botched their rollout of Enbrel? That's why they came to be acquired by Amgen. Also, it allowed Humira to be approved sooner and grow faster. Not saying that that's what will happen but if REGN is slow on the output and AMGN is a model of efficiency, the month may not make any difference.